Research article describing the research protocol and clinical characteristics of the first patient cohort of the Canadian Biomarker Integration Network in Depression (CAN-BIND) study, a major CANMAT-led initiative to discover biomarkers for antidepressant treatment response to advance personalized treatments for depression.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.